ImmunoTargets and Therapy
Volume 12, 2023 - Issue
Open access
135
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH
NOTCH1 Mutations Predict Superior Outcomes of Immune Checkpoint Blockade in Non-Small Cell Lung Cancer
Qingyuan Huang1 Departments of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, People’s Republic of China;2 Institute of Thoracic Oncology, Fudan University, Shanghai, 200032, People’s Republic of China;3 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, People’s Republic of Chinahttps://orcid.org/0000-0003-4389-6188View further author information
, Hang Cao1 Departments of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, People’s Republic of China;2 Institute of Thoracic Oncology, Fudan University, Shanghai, 200032, People’s Republic of China;3 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, People’s Republic of ChinaView further author information
, Qianlan Yao3 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, People’s Republic of China;4 Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, 200032, People’s Republic of China;5 Institute of Pathology, Fudan University, Shanghai, 200032, People’s Republic of ChinaView further author information
, Xiaoyan Zhou3 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, People’s Republic of China;4 Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, 200032, People’s Republic of China;5 Institute of Pathology, Fudan University, Shanghai, 200032, People’s Republic of ChinaView further author information
, Hang Li1 Departments of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, People’s Republic of China;2 Institute of Thoracic Oncology, Fudan University, Shanghai, 200032, People’s Republic of China;3 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, People’s Republic of ChinaView further author information
, Qianming Bai3 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, People’s Republic of China;4 Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, 200032, People’s Republic of China;5 Institute of Pathology, Fudan University, Shanghai, 200032, People’s Republic of Chinahttps://orcid.org/0000-0003-0657-9845View further author information
& Hong Hu1 Departments of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, People’s Republic of China;2 Institute of Thoracic Oncology, Fudan University, Shanghai, 200032, People’s Republic of China;3 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, People’s Republic of ChinaCorrespondence[email protected] [email protected]
View further author information
show allView further author information
Pages 165-173
|
Received 06 Aug 2023, Accepted 07 Nov 2023, Published online: 04 Dec 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.